Yoona Kim, Founder CEO at ArineAs ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high.In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may inadvertently contribute to dangerous polypharmacy and medication mismanagement. She comments on the critical challenges facing healthcare providers, from fragmented medication tracking to rapidly evolving drug knowledge, and explores how AI-powered solutions can help ensure safe, effective medication management in an increasingly automated healthcare landscape.What are the potential benefits and risks of ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery? How can these services impact patient access to medications and adherence to treatment plans?Yoona Kim, Founder CEO at Arine: Ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery offer clear benefits to patients, particularly those with acute health needs. Instead of having to pick up medication from the pharmacy – while potentially feeling under the weather – patients can have medications delivered straight to their door within hours. It’s easy to see why this level of convenience is appealing, especially as we grow accustomed to rapid delivery in other areas of our lives, such as grocery shopping.However, this convenience comes with considerable risks in our already fragmented healthcare ecosystem. To start, it complicates providers’ ability to track a patient’s medications

Arine ranked 236 on the 2024 Inc. 5000 list and was named the 5th fastest-growing company in the AI category.